Single dose oral diflunisal for acute postoperative pain in adults.
BACKGROUND
Diflunisal is a long-acting non-steroidal anti-inflammatory drug (NSAID) most commonly used to treat acute postoperative pain or chronic joint pain from osteoarthritis and rheumatoid arthritis. This review analyses the effectiveness and harm of different doses of diflunisal in the context of moderate to severe postoperative pain.


OBJECTIVE
To assess efficacy, duration of action, and associated adverse events of single dose oral diflunisal in acute postoperative pain in adults.


METHODS
We searched Cochrane CENTRAL, MEDLINE, EMBASE and the Oxford Pain Relief Database for studies to January 2010.


METHODS
Randomised, double blind, placebo-controlled trials of single dose orally administered diflunisal in adults with moderate to severe acute postoperative pain.


METHODS
Two review authors independently assessed trial quality and extracted data. Pain relief or pain intensity data were extracted and converted into the dichotomous outcome of number of participants with at least 50% pain relief over 4 to 6 hours, from which relative risk and number-needed-to-treat-to-benefit (NNT) were calculated. Numbers of participants using rescue medication over specified time periods, and time to use of rescue medication, were sought as additional measures of efficacy. Information on adverse events and withdrawals were collected.


RESULTS
Nine studies in dental, orthopedic and gynaecological surgery met the inclusion criteria, testing doses of diflunisal from 125 mg to 1000 mg.For diflunisal 1000 mg, the NNT for at least 50% pain relief over 4 to 6 hours was 2.1 (1.8 to 2.6) (6 studies, 391 participants); the NNT to prevent remedication within 6 hours was 1.9 (1.7 to 2.3), and within 12 hours was 2.2 (1.9 to 2.7) (6 studies, 409 participants). More participants experienced adverse events with diflunisal 100 mg than with placebo, but none were serious or led to withdrawal.For diflunisal 500 mg, the NNT for at least 50% pain relief over 4 to 6 hours was 2.6 (2.1 to 3.3) (6 studies, 357 participants); the NNT to prevent remedication within 6 hours was 2.6 (2.1 to 3.4) (6 studies, 390 participants), and within 12 hours was 2.9 (2.3 to 4.0) (5 studies, 329 participants). Adverse events did not differ significantly from placebo.


CONCLUSIONS
Diflunisal has an analgesic effect similar to other NSAIDs in single dose, but benefits from providing significant analgesia for about twelve hours. This property may be useful when regular dosing is needed, or when taking several doses of a shorter acting analgesic is impractical.
Wasey
Jack O
JO
Magdalen College, University of Oxford, High Street, Oxford, Oxfordshire, UK, OX1 4AU.
Derry
Sheena
S
Moore
R Andrew
RA
McQuay
Henry J
HJ
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D004061:Diflunisal / Q000008:administration & dosage*; D006801:Humans; D010149:Postoperative Pain / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004061:Diflunisal
N Engl J Med. 2001 Aug 9;345(6):433-42
11496855
Control Clin Trials. 1996 Feb;17(1):1-12
8721797
Ann Intern Med. 1987 Aug;107(2):224-33
3300460
Int J Oral Maxillofac Surg. 1987 Aug;16(4):448-53
3117918
J Int Med Res. 1978;6(3):172-9
348532
Pain. 1997 Feb;69(3):311-315
9085306
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004768
19370609
JAMA. 1982 Nov 5;248(17):2139-42
6750171
Pain. 1996 Aug;66(2-3):229-37
8880845
J Int Med Res. 1991 May-Jun;19(3):210-8
1936510
Br Dent J. 2004 Oct 9;197(7):407-11; discussion 397
15475903
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004771
19370610
Int J Oral Surg. 1979 Apr;8(2):102-13
112068
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004309
19370600
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004602
18843665
Pain. 2005 Aug;116(3):322-331
15979792
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004234
19160232
Rev Esp Estomatol. 1981 May-Jun;29(3):171-8
6949233
J Clin Pharmacol. 1986 Nov-Dec;26(8):700-5
3540032
Curr Med Res Opin. 1978;5(7):536-43
359246
Br Med J (Clin Res Ed). 1988 May 7;296(6632):1313-6
3133061
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD002763
19588335
Minerva Stomatol. 1987 Apr;36(4):297-300
3299038
Oral Surg Oral Med Oral Pathol. 1989 Sep;68(3):273-8
2788853
Br Dent J. 1982 Jan 5;152(1):18-20
6951584
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006865
17943921
BMJ. 1995 Feb 18;310(6977):452-4
7873954
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD001548
19588326
Minerva Stomatol. 1984 Jul-Aug;33(4):645-50
6387433
Pharmacotherapy. 1983 Mar-Apr;3(2 Pt 2):38S-46S
6344038
G Anest Stomatol. 1990 Apr-Jun;19(2):27-36
2245928
J R Soc Med. 1982 Sep;75(9):705-8
7120254
Anesth Prog. 1989 Jul-Oct;36(4-5):206-9
2490035
J Clin Pharmacol. 1982 Feb-Mar;22(2-3):89-96
7068938
Postgrad Med J. 2005 Mar;81(953):155-60
15749790
Arzneimittelforschung. 1983;33(9):1331-4
6357208
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD004604
19821329
Schweiz Med Wochenschr. 1978 Jun 3;108(22):832-7
306681
BMJ. 1997 Sep 13;315(7109):635-40
9310564
Lancet. 1999 Jan 23;353(9149):307-14
9929039
Br J Clin Pharmacol. 1977 Feb;4 Suppl 1:31S-36S
328032
Drug Metab Dispos. 1975 Nov-Dec;3(6):453-66
1220
Pain. 2001 Mar;91(1-2):189-94
11240091
Aust Dent J. 2002 Dec;47(4):327-30
12587769
Drugs Aging. 1991 Mar;1(2):130-43
1794009
Dtsch Med Wochenschr. 1977 Dec 30;102(52):1920-2
340182
Proc Finn Dent Soc. 1980;76(5-6):262-6
7019903
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001547
19160199
Pain. 1997 Jan;69(1-2):127-30
9060022
Curr Med Res Opin. 1978;5(7):544-7
359247
Pain. 1996 Aug;66(2-3):239-46
8880846
Pharmacotherapy. 1988;8(3):201-9
3050906
Pain. 1998 Dec;78(3):209-216
9870574
Pharmacotherapy. 1983 Mar-Apr;3(2 Pt 2):47S-54S
6344039
Pharmacology. 1983;27 Suppl 1:74-80
6361794
Br J Clin Pharmacol. 1977 Feb;4 Suppl 1:39S-43S
328033
Curr Med Res Opin. 1978;5(7):525-35
359245
Int J Oral Maxillofac Surg. 1987 Dec;16(6):700-5
3125269
Pain. 1997 Aug;72(1-2):95-7
9272792